JP2016529316A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529316A5 JP2016529316A5 JP2016540407A JP2016540407A JP2016529316A5 JP 2016529316 A5 JP2016529316 A5 JP 2016529316A5 JP 2016540407 A JP2016540407 A JP 2016540407A JP 2016540407 A JP2016540407 A JP 2016540407A JP 2016529316 A5 JP2016529316 A5 JP 2016529316A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- vector
- influenza
- animal
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 22
- 241001465754 Metazoa Species 0.000 claims 7
- 206010022000 influenza Diseases 0.000 claims 6
- 244000052769 pathogen Species 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000000241 respiratory effect Effects 0.000 claims 5
- 241000725643 Respiratory syncytial virus Species 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 201000004792 malaria Diseases 0.000 claims 4
- 230000001717 pathogenic effect Effects 0.000 claims 4
- 241000193738 Bacillus anthracis Species 0.000 claims 3
- 241000894006 Bacteria Species 0.000 claims 3
- 108700019146 Transgenes Proteins 0.000 claims 3
- 230000002163 immunogen Effects 0.000 claims 3
- 241000712461 unidentified influenza virus Species 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 2
- 206010069767 H1N1 influenza Diseases 0.000 claims 2
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 claims 2
- 241000430519 Human rhinovirus sp. Species 0.000 claims 2
- 102100024324 Toll-like receptor 3 Human genes 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000000556 agonist Substances 0.000 claims 2
- 206010064097 avian influenza Diseases 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 230000001681 protective effect Effects 0.000 claims 2
- 201000010740 swine influenza Diseases 0.000 claims 2
- 241000272525 Anas platyrhynchos Species 0.000 claims 1
- XFTWUNOVBCHBJR-UHFFFAOYSA-N Aspergillomarasmine A Chemical group OC(=O)C(N)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O XFTWUNOVBCHBJR-UHFFFAOYSA-N 0.000 claims 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 1
- 241000711573 Coronaviridae Species 0.000 claims 1
- 241000709661 Enterovirus Species 0.000 claims 1
- 241000287828 Gallus gallus Species 0.000 claims 1
- 102000003886 Glycoproteins Human genes 0.000 claims 1
- 108090000288 Glycoproteins Proteins 0.000 claims 1
- 101710154606 Hemagglutinin Proteins 0.000 claims 1
- 241000598171 Human adenovirus sp. Species 0.000 claims 1
- 208000002979 Influenza in Birds Diseases 0.000 claims 1
- 241000186359 Mycobacterium Species 0.000 claims 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 claims 1
- 102000005348 Neuraminidase Human genes 0.000 claims 1
- 108010006232 Neuraminidase Proteins 0.000 claims 1
- 102000011931 Nucleoproteins Human genes 0.000 claims 1
- 108010061100 Nucleoproteins Proteins 0.000 claims 1
- 208000009620 Orthomyxoviridae Infections Diseases 0.000 claims 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 1
- 108010039918 Polylysine Proteins 0.000 claims 1
- 101710194807 Protective antigen Proteins 0.000 claims 1
- 101710176177 Protein A56 Proteins 0.000 claims 1
- 206010037742 Rabies Diseases 0.000 claims 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims 1
- 241000191940 Staphylococcus Species 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 108010055044 Tetanus Toxin Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 230000002500 effect on skin Effects 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 239000008241 heterogeneous mixture Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 231100000518 lethal Toxicity 0.000 claims 1
- 230000001665 lethal effect Effects 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 229920000656 polylysine Polymers 0.000 claims 1
- 230000004044 response Effects 0.000 claims 1
- 230000001932 seasonal effect Effects 0.000 claims 1
- 229940118376 tetanus toxin Drugs 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361874505P | 2013-09-06 | 2013-09-06 | |
| US61/874,505 | 2013-09-06 | ||
| PCT/US2014/054234 WO2015035128A1 (en) | 2013-09-06 | 2014-09-05 | Methods and compositions for viral vectored vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016529316A JP2016529316A (ja) | 2016-09-23 |
| JP2016529316A5 true JP2016529316A5 (OSRAM) | 2017-10-19 |
Family
ID=52625855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540407A Pending JP2016529316A (ja) | 2013-09-06 | 2014-09-05 | ウイルスベクター化ワクチンのための方法及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20150071964A1 (OSRAM) |
| EP (1) | EP3041503A4 (OSRAM) |
| JP (1) | JP2016529316A (OSRAM) |
| KR (1) | KR20160049010A (OSRAM) |
| AU (1) | AU2014315124A1 (OSRAM) |
| CA (1) | CA2923406A1 (OSRAM) |
| MX (1) | MX2016002823A (OSRAM) |
| WO (1) | WO2015035128A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10183069B2 (en) | 2011-03-21 | 2019-01-22 | Altimmune Inc. | Rapid and prolonged immunologic-therapeutic |
| EP3525763B1 (en) | 2016-10-12 | 2025-03-05 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| CA3132697A1 (en) * | 2019-04-06 | 2020-10-15 | Scot ROBERTS | Broad and long-lasting influenza vaccine |
| EP4138902A4 (en) * | 2020-04-20 | 2024-06-12 | Greffex, Inc. | MANUFACTURE OF BROADLY REACTIVE CORONAVIRUS VACCINES AND CORRESPONDING DESIGNS AND USES |
| JP2024517181A (ja) | 2021-04-28 | 2024-04-19 | ウエヌイグレックオ・ファーマ | 組合せ治療としてｆｘｒアゴニストを使用するｔｌｒ３アゴニストの効果の強い増強 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2712673C2 (de) * | 1977-03-23 | 1983-12-15 | Krauss U. Reichert Gmbh + Co Kg Spezialmaschinenfabrik, 7012 Fellbach | Stoßmessermaschine |
| US20030134815A1 (en) * | 1991-08-20 | 2003-07-17 | The Govt. Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services | Adenovirus mediated transfer of genes to the gastrointestinal tract |
| US20050271689A1 (en) * | 2003-07-11 | 2005-12-08 | Chun-Ming Huang | Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| US7439349B2 (en) * | 2002-07-03 | 2008-10-21 | Andres Salazar | Method for preparation of large volume batches of poly-ICLC with increased biological potency; therapeutic, clinical and veterinary uses thereof |
| US8592391B2 (en) * | 2003-07-01 | 2013-11-26 | Andres Salazar | Method for therapeutic, clinical and veterinary use poly-ICLC |
| US7834064B2 (en) * | 2005-01-03 | 2010-11-16 | Andres Mario Salazar | Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs |
| EP1899470A4 (en) * | 2005-05-23 | 2009-07-29 | Vaxin Inc | SYSTEM FOR THE FAST MANUFACTURE OF REPLICATED COMPETENCE OF ADENOVIRUS-FREE RECOMBINANT ADENOVIRUS VECTORS WITH HIGH TITER |
| AU2006279612B2 (en) * | 2005-08-15 | 2013-03-21 | Altimmune Inc. | Immunization of avians by administration of non-replicating vectored vaccines |
| EP1996238B1 (en) * | 2006-02-28 | 2016-04-06 | Vaxart, Inc. | Chimeric Adenoviral Vectors and dsRNA as TLR3 Agonist |
| AU2009253780B2 (en) * | 2008-06-05 | 2014-08-14 | Immunovaccine Technologies Inc. | Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| JP2012504140A (ja) * | 2008-09-26 | 2012-02-16 | オーバーン・ユニバーシティ | 非複製性ベクターワクチンの粘膜投与による鳥類の免疫処置 |
| US9603919B2 (en) * | 2009-03-31 | 2017-03-28 | Japan As Represented By The Director-General Of National Institute Of Infectious Diseases | Method for prophylaxis of influenza using vaccine for intranasal administration |
| BRPI1012951A2 (pt) * | 2009-06-09 | 2016-07-26 | Defyrus Inc | "administração de interferon para profilaxia ou tratamento de infecção por patôgeno" |
| EP2688588B1 (en) * | 2011-03-21 | 2017-08-09 | Altimmune Inc. | Rapid and prolonged immunologic therapeutic |
-
2014
- 2014-09-05 WO PCT/US2014/054234 patent/WO2015035128A1/en not_active Ceased
- 2014-09-05 AU AU2014315124A patent/AU2014315124A1/en not_active Abandoned
- 2014-09-05 EP EP14841665.4A patent/EP3041503A4/en not_active Withdrawn
- 2014-09-05 KR KR1020167008956A patent/KR20160049010A/ko not_active Withdrawn
- 2014-09-05 CA CA2923406A patent/CA2923406A1/en not_active Abandoned
- 2014-09-05 US US14/478,040 patent/US20150071964A1/en not_active Abandoned
- 2014-09-05 JP JP2016540407A patent/JP2016529316A/ja active Pending
- 2014-09-05 MX MX2016002823A patent/MX2016002823A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rajao et al. | Swine as a model for influenza A virus infection and immunity | |
| JP2016529316A5 (OSRAM) | ||
| WO2018089851A3 (en) | Influenza vaccine | |
| AR090469A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| IL253187B (en) | Novel multivalent nanoparticle-based vaccines | |
| PH12018500856A1 (en) | Respiratory syncytial virus vaccine | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| WO2009068992A8 (en) | Vaccination with multiple clades of h5 influenza a virus | |
| ES2588183T3 (es) | Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal | |
| EP4233898A3 (en) | Influenza mrna vaccines | |
| WO2017070620A3 (en) | Broad spectrum influenza virus vaccine | |
| PH12015501482A1 (en) | Nasal influenza vaccine composition | |
| JP2016222689A5 (ja) | 合成ペプチド及び乾燥粉末薬剤輸送システム | |
| WO2009092038A8 (en) | Influenza dna vaccination and methods of use thereof | |
| WO2010037027A3 (en) | Immunization of avians by mucosal administration of non-replicating vectored vaccines | |
| WO2015052543A3 (en) | Malaria vaccination | |
| WO2010077986A3 (en) | Production of influenza vaccines | |
| AU2011280259A8 (en) | Influenza vaccine | |
| Lambe | Novel viral vectored vaccines for the prevention of influenza | |
| EA201290897A1 (ru) | Вакцины для пандемического гриппа | |
| WO2011156641A3 (en) | Microneedle arrays for active agent delivery | |
| EA201400235A1 (ru) | Вакцины против гриппа на основе н5 | |
| PE20170429A1 (es) | Vacuna en vector recombinante de adenovirus aviar serotipo 9 | |
| EP2329845A4 (en) | BIRD GRAPEVIRUS ANTIGEN AND BOOSTER IMMUNIZATION PROCEDURE FOR BIRD FLUID VACCINE IN COMBINATION WITH A MUCOSAL ADJUVAN WITH EFFICACY THROUGH ORAL ADMINISTRATION | |
| JP2013515490A5 (OSRAM) |